Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 29 (2) , 79-91
- https://doi.org/10.1016/0198-8859(90)90071-v
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989
- Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseBlood, 1986
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases.Journal of Clinical Oncology, 1983
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood, 1981
- Immunoadsorption for Removal of a and B Blood-Group AntibodiesNew England Journal of Medicine, 1981
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958